NCT07260175
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07260175
Title Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma (adIVO)
Acronym adIVO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Uniklinik RWTH Aachen RECRUITING Aachen 52074 Germany Details
Universitätsklinikum Bonn RECRUITING Bonn 53127 Germany Details
Krankenhaus Nordwest RECRUITING Frankfurt 60488 Germany Details
Universitätsklinikum Frankfurt RECRUITING Frankfurt 60590 Germany Details
Universitätsmedizin Göttingen RECRUITING Göttingen 37099 Germany Details
Uniklinikum Jena RECRUITING Jena 7747 Germany Details
Universitätsklinikum Mannheim RECRUITING Mannheim 68167 Germany Details
Klinikum rechts der Isar TU München RECRUITING München 81675 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field